Ironwood Pharmaceuticals, Inc.
IRWD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $880 | -$1,002,239 | $175,065 | $528,448 |
| Dep. & Amort. | $2,011 | $1,575 | $1,418 | $1,500 |
| Deferred Tax | $68,090 | $72,637 | $65,739 | -$333,294 |
| Stock-Based Comp. | $29,850 | $32,005 | $27,048 | $22,281 |
| Change in WC | $739 | $11,279 | $2,820 | $17,731 |
| Other Non-Cash | $1,979 | $1,068,170 | $1,673 | $25,229 |
| Operating Cash Flow | $103,549 | $183,427 | $273,763 | $261,895 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$142 | -$273 | -$136 | -$265 |
| Net Acquisitions | $0 | -$1,026,045 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$142 | -$1,026,318 | -$136 | -$265 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$115,000 | $300,000 | -$120,699 | $0 |
| Stock Issued | $11,013 | $6,357 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$126,394 | -$24,131 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2,983 | -$29,197 | $9,540 | $19,581 |
| Financing Cash Flow | -$106,970 | $277,160 | -$237,553 | -$4,550 |
| Forex Effect | -$32 | -$53 | $0 | $0 |
| Net Chg. in Cash | -$3,595 | -$565,784 | $36,074 | $257,080 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $92,154 | $657,938 | $621,864 | $364,784 |
| End Cash | $88,559 | $92,154 | $657,938 | $621,864 |
| Free Cash Flow | $103,407 | $183,154 | $273,627 | $261,630 |